MedPath
HSA Approval

ALMET CAPSULES

SIN17214P

ALMET CAPSULES

ALMET CAPSULES

April 2, 2025

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

CAPSULE, LIQUID FILLED

ORAL

Medical Information

A03AX58

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

XL LABORATORIES PRIVATE LIMITED

Active Ingredients

Alverine Citrate

60mg

Alverine

Simeticone

300mg

Simethicone

Documents

Patient Information Leaflets

ALMET CAPSULES PIL.pdf

Approved: April 2, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALMET CAPSULES - HSA Approval | MedPath